261 related articles for article (PubMed ID: 10543761)
1. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.
Kenny DJ; Russell P; Rogers D; Eley SM; Titball RW
Antimicrob Agents Chemother; 1999 Nov; 43(11):2773-5. PubMed ID: 10543761
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.
Heine HS; England MJ; Waag DM; Byrne WR
Antimicrob Agents Chemother; 2001 Jul; 45(7):2119-21. PubMed ID: 11408233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
[TBL] [Abstract][Full Text] [Related]
5. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
8. Burkholderia vaccines: are we moving forward?
Choh LC; Ong GH; Vellasamy KM; Kalaiselvam K; Kang WT; Al-Maleki AR; Mariappan V; Vadivelu J
Front Cell Infect Microbiol; 2013; 3():5. PubMed ID: 23386999
[TBL] [Abstract][Full Text] [Related]
9. A Quadruplex Real-Time PCR Assay for the Rapid Detection and Differentiation of the Most Relevant Members of the B. pseudomallei Complex: B. mallei, B. pseudomallei, and B. thailandensis.
Lowe CW; Satterfield BA; Nelson DB; Thiriot JD; Heder MJ; March JK; Drake DS; Lew CS; Bunnell AJ; Moore ES; O'Neill KL; Robison RA
PLoS One; 2016; 11(10):e0164006. PubMed ID: 27736903
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
[TBL] [Abstract][Full Text] [Related]
11. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei.
Gee JE; Sacchi CT; Glass MB; De BK; Weyant RS; Levett PN; Whitney AM; Hoffmaster AR; Popovic T
J Clin Microbiol; 2003 Oct; 41(10):4647-54. PubMed ID: 14532197
[TBL] [Abstract][Full Text] [Related]
12. Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei.
Paauw A; Scholz HC; Mars-Groenendijk RH; Dekker LJM; Luider TM; van Leeuwen HC
PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011006. PubMed ID: 36607891
[TBL] [Abstract][Full Text] [Related]
13. Current Advances in
Wang G; Zarodkiewicz P; Valvano MA
Cells; 2020 Dec; 9(12):. PubMed ID: 33322641
[TBL] [Abstract][Full Text] [Related]
14.
Papp-Wallace KM; Shapiro AB; Becka SA; Zeiser ET; LiPuma JJ; Lane DJ; Panchal RG; Mueller JP; O'Donnell JP; Miller AA
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318017
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Mast
Edler C; Derschum H; Köhler M; Neubauer H; Frickmann H; Hagen RM
Eur J Microbiol Immunol (Bp); 2017 Mar; 7(1):15-36. PubMed ID: 28386468
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
Gilad J
Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
[TBL] [Abstract][Full Text] [Related]
18. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species.
Viktorov DV; Zakharova IB; Podshivalova MV; Kalinkina EV; Merinova OA; Ageeva NP; Antonov VA; Merinova LK; Alekseev VV
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S103-10. PubMed ID: 19121669
[TBL] [Abstract][Full Text] [Related]
19. Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker.
Zajdowicz SL; Jones-Carson J; Vazquez-Torres A; Jobling MG; Gill RE; Holmes RK
PLoS One; 2011; 6(6):e21523. PubMed ID: 21720554
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria.
Somprasong N; Hall CM; Webb JR; Sahl JW; Wagner DM; Keim P; Currie BJ; Schweizer HP
mBio; 2020 Apr; 11(2):. PubMed ID: 32291300
[No Abstract] [Full Text] [Related]
[Next] [New Search]
